-受体阻滞剂对高血压和心力衰竭伴射血分数降低的影响:随机对照试验的系统评价

Q4 Medicine Open Hypertension Journal Pub Date : 2019-01-01 DOI:10.15713/ins.johtn.0157
Jeremy O. Go, L. D. Santiago, A. Miranda, Raul D. Jara
{"title":"-受体阻滞剂对高血压和心力衰竭伴射血分数降低的影响:随机对照试验的系统评价","authors":"Jeremy O. Go, L. D. Santiago, A. Miranda, Raul D. Jara","doi":"10.15713/ins.johtn.0157","DOIUrl":null,"url":null,"abstract":"General objective The general objective of this study was to evaluate the effects of the different beta-blockers in patients with HTN and HFrEF. Specific objectives The specific objectives of this study were as follows: • To discuss the pathophysiologic mechanisms behind the development of HTN and HF • To determine which beta-blockers are effective in reducing rates of hospitalization, morbidity, and mortality among hypertensive patients with HFrEF.","PeriodicalId":38918,"journal":{"name":"Open Hypertension Journal","volume":"3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Effect of Beta-blockers on Hypertension and Heart Failure with Reduced Ejection Fraction: A Systematic Review of Randomized Controlled Trials\",\"authors\":\"Jeremy O. Go, L. D. Santiago, A. Miranda, Raul D. Jara\",\"doi\":\"10.15713/ins.johtn.0157\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"General objective The general objective of this study was to evaluate the effects of the different beta-blockers in patients with HTN and HFrEF. Specific objectives The specific objectives of this study were as follows: • To discuss the pathophysiologic mechanisms behind the development of HTN and HF • To determine which beta-blockers are effective in reducing rates of hospitalization, morbidity, and mortality among hypertensive patients with HFrEF.\",\"PeriodicalId\":38918,\"journal\":{\"name\":\"Open Hypertension Journal\",\"volume\":\"3 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open Hypertension Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15713/ins.johtn.0157\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Hypertension Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15713/ins.johtn.0157","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 3

摘要

本研究的总体目的是评估不同受体阻滞剂对HTN和HFrEF患者的影响。本研究的具体目的如下:•讨论HTN和HF发展背后的病理生理机制•确定哪种β受体阻滞剂能有效降低高血压HFrEF患者的住院率、发病率和死亡率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Effect of Beta-blockers on Hypertension and Heart Failure with Reduced Ejection Fraction: A Systematic Review of Randomized Controlled Trials
General objective The general objective of this study was to evaluate the effects of the different beta-blockers in patients with HTN and HFrEF. Specific objectives The specific objectives of this study were as follows: • To discuss the pathophysiologic mechanisms behind the development of HTN and HF • To determine which beta-blockers are effective in reducing rates of hospitalization, morbidity, and mortality among hypertensive patients with HFrEF.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Open Hypertension Journal
Open Hypertension Journal Medicine-Cardiology and Cardiovascular Medicine
自引率
0.00%
发文量
0
期刊最新文献
Implementation of a Resistant Hypertension Control Program in a Low-income Primary Care Setting in a High-Income Country: Lessons Learned and Global Applicability Troponin and B-type Natriuretic Peptides Biomarkers in the Management of Hypertension Hypertension in end-stage kidney disease Confirming a Diagnosis of "Hypertension" Sodium-glucose Co-transporter 2 Inhibitors and Blood Pressure Reduction among Patients with Diabetes, Cardiovascular Disease, Chronic Kidney Disease
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1